Kidney Disease Clinical Trials in New York

Showing 61-80 of 414 trials

A Study of Safety and Efficacy of KFA115 Alone and in Combo With Pembrolizumab in Patients With Select Advanced Cancers

NCT05544929

The purpose of this study is to characterize the safety and tolerability of KFA115 and KFA115 in combination with pembrolizumab in patients with select advanced cancers, and to identify the maximum tolerated dose and/or recommended dose.

Carcinoma, Non-Small-Cell LungCutaneous MelanomaCarcinoma, Renal Cell+9 more

Novartis Pharmaceuticals126 participantsStarted Oct 2022

Boston, Massachusetts, United States • Boston, Massachusetts, United States • New York, New York, United States +16 more locations

RECRUITINGNA< 1 mile

Transcutaneous Auricular Vagus Nerve Stimulation (taVNS) in Chronic Kidney Disease (CKD)

NCT06927024

30 patients will participate in a prospective randomized clinical trial to test the safety, tolerability and efficacy of transcutaneous auricular vagus nerve stimulation (taVNS) for autonomic nervous system (ANS) dysfunction in the chronic kidney disease (CKD) stage 3-5 setting.

Chronic Kidney Diseases

NYU Langone Health30 participantsStarted Oct 2025

New York, New York, United States

A Study of Safety and Efficacy of KFA115 Alone and in Combo With Pembrolizumab in Patients With Select Advanced Cancers

Transcutaneous Auricular Vagus Nerve Stimulation (taVNS) in Chronic Kidney Disease (CKD)

Kidney Disease Trials in Other Cities

Safety & Efficacy of DCR-PHXC in Patients With PH1 and ESRD

The HistoSonics Edison™ System for Treatment of Primary Solid Renal Tumors Using Histotripsy (#HOPE4KIDNEY)

Axitinib With or Without Anti-OX40 Antibody PF-04518600 in Treating Patients With Metastatic Kidney Cancer

VIRTUUS Children's Study

Tipifarnib for the Treatment of Advanced Solid Tumors, Lymphoma, or Histiocytic Disorders With HRAS Gene Alterations, a Pediatric MATCH Treatment Trial

Pembrolizumab Plus Lenvatinib for First-line Advanced/Metastatic Non-clear Cell Renal Cell Carcinoma (1L nccRCC) (MK-3475-B61)

Decision Aid (DA) for Renal Patients

Study to Evaluate the Safety and Efficacy of the GGTA1 KO Thymokidney in Patients With ESRD

CAR-T Cell Therapy for Desensitization in Kidney Transplantation

Study of CHS-388 (Formerly Known as SRF388) in Patients With Advanced Solid Tumors

Comparison of the Human Acellular Vessel (HAV) With Fistulas as Conduits for Hemodialysis

A Phase 3, Randomized, Double Blind, Placebo-Controlled, Multi-Center, Withdrawal Study of MCI-196 in CKD on Dialysis With Hyperphosphatemia

Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)

Observational Basket Trial to Collect Tissue to Develop and Train a Live Tumor Diagnostic Platform

Maturation of Arteriovenous Fistula With Automated Sonography Assessments Trial

Dissemination of the Donor Application: Utilizing Social Media to Identify Potential Live Organ Donors

A Study to Evaluate Safety, Efficacy and Pharmacokinetics of Paricalcitol For Treatment of Secondary Hyperparathyroidism (SHPT) in Pediatric Participants With Stage 5 Chronic Kidney Disease (CKD)

A Multicenter, Prospective Blood Collection Study in a Kidney Transplant Population

Other Conditions in New York